Previous Article | Next Article ![]()
Journal of Virology, February 2006, p. 1922-1938, Vol. 80, No. 4
0022-538X/06/$08.00+0 doi:10.1128/JVI.80.4.1922-1938.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Maud Szynal,1,
Yvette Cleuter,1
Makram Merimi,1
Hugues Duvillier,1
Françoise Lallemand,1
Claude Bagnis,3
Philip Griebel,4
Christos Sotiriou,1
Arsène Burny,1
Philippe Martiat,1 and
Anne Van den Broeke1*
Laboratory of Experimental Hematology, Bordet Institute, 1000 Brussels, Belgium,1 Institute of Pathological Physiology, Charles University, Prague, Czech Republic,2 Etablissement Français du Sang, 13009 Marseille, France,3 Vaccine and Infectious Disease Organization, S7H5E3 Saskatoon, Canada4
Received 22 August 2005/ Accepted 18 November 2005
Large-animal models for leukemia have the potential to aid in the understanding of networks that contribute to oncogenesis. Infection of cattle and sheep with bovine leukemia virus (BLV), a complex retrovirus related to human T-cell leukemia virus type 1 (HTLV-1), is associated with the development of B-cell leukemia. Whereas the natural disease in cattle is characterized by a low tumor incidence, experimental infection of sheep leads to overt leukemia in the majority of infected animals, providing a model for studying the pathogenesis associated with BLV and HTLV-1. TaxBLV, the major oncoprotein, initiates a cascade of events leading toward malignancy, although the basis of transformation is not fully understood. We have taken a cross-species ovine-to-human microarray approach to identify TaxBLV-responsive transcriptional changes in two sets of cultured ovine B cells following retroviral vector-mediated delivery of TaxBLV. Using cDNA-spotted microarrays comprising 10,336 human genes/expressed sequence tags, we identified a cohort of differentially expressed genes, including genes related to apoptosis, DNA transcription, and repair; proto-oncogenes; cell cycle regulators; transcription factors; small Rho GTPases/GTPase-binding proteins; and previously reported TaxHTLV-1-responsive genes. Interestingly, genes known to be associated with human neoplasia, especially B-cell malignancies, were extensively represented. Others were novel or unexpected. The results suggest that TaxBLV deregulates a broad network of interrelated pathways rather than a single B-lineage-specific regulatory process. Although cross-species approaches do not permit a comprehensive analysis of gene expression patterns, they can provide initial clues for the functional roles of genes that participate in B-cell transformation and pinpoint molecular targets not identified using other methods in animal models.
P.K. and M.S. contributed equally to this work.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|